Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Same price at every dose
Patient safety advice includes: Maintaining good injection technique and site rotation to minimise local reactions Staying up to date with routine vaccinations, including annual influenza and pneumococcal vaccines as recommended for people with diabetes Monitoring for signs of infection and seeking prompt medical advice if concerned Following 'sick day rules' during illness maintain hydration, continue medication if possible, but temporarily pause GLP-1 treatment if unable to keep fluids down Reporting suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app) Patients should not discontinue their GLP-1 receptor agonist due to concerns about immune function without first consulting their prescribing clinician
The diuretic and natriuretic effects of GLP-1 are mediated through downregulation of sodiumhydrogen exchanger 3 (NHE3) activity in the renal proximal tubule that consequently affects renal hemodynamics [112]
95% CI: 0.89-1.17)
